Concert Pharmaceuticals, Inc. announced the appointment of Marc Becker as Chief Financial Officer, effective January 4, 2018. Mr. Becker is a seasoned financial executive with more than 15 years of experience in the biotechnology industry. Mr. Becker joins Concert with a strong track record of strategic and financial experience at high-growth biotechnology companies. Prior to joining Concert, he was Senior Vice President and Chief Financial Officer at CRISPR Therapeutics from February 2016 to September 2017.